GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (LTS:0QQD) » Definitions » Beneish M-Score
中文

Zimmer Biomet Holdings (LTS:0QQD) Beneish M-Score

: -2.52 (As of Today)
View and export this data going back to 2014. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.52 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Zimmer Biomet Holdings's Beneish M-Score or its related term are showing as below:

LTS:0QQD' s Beneish M-Score Range Over the Past 10 Years
Min: -2.83   Med: -2.48   Max: -2.07
Current: -2.52

During the past 13 years, the highest Beneish M-Score of Zimmer Biomet Holdings was -2.07. The lowest was -2.83. And the median was -2.48.


Zimmer Biomet Holdings Beneish M-Score Historical Data

The historical data trend for Zimmer Biomet Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.45 -2.48 -2.72 -2.47 -2.52

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -2.45 -2.49 -2.49 -2.52

Competitive Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Beneish M-Score falls into.



Zimmer Biomet Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zimmer Biomet Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9643+0.528 * 0.9872+0.404 * 0.984+0.892 * 1.0051+0.115 * 1.0359
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9656+4.679 * -0.018036-0.327 * 1.0039
=-2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was CHF1,247 Mil.
Revenue was 1677.798 + 1577.539 + 1683.388 + 1694.591 = CHF6,633 Mil.
Gross Profit was 1211.844 + 1111.006 + 1210.228 + 1231.1 = CHF4,764 Mil.
Total Current Assets was CHF3,986 Mil.
Total Assets was CHF18,591 Mil.
Property, Plant and Equipment(Net PPE) was CHF1,782 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF854 Mil.
Selling, General, & Admin. Expense(SGA) was CHF2,548 Mil.
Total Current Liabilities was CHF2,471 Mil.
Long-Term Debt & Capital Lease Obligation was CHF4,335 Mil.
Net Income was 362.524 + 146.365 + 188.724 + 215.179 = CHF913 Mil.
Non Operating Income was -74.546 + -25.009 + -30.163 + -32.763 = CHF-162 Mil.
Cash Flow from Operations was 508.848 + 303.705 + 313.249 + 284.776 = CHF1,411 Mil.
Total Receivables was CHF1,287 Mil.
Revenue was 1700.263 + 1625.216 + 1728.702 + 1545.778 = CHF6,600 Mil.
Gross Profit was 1215.552 + 1150.051 + 1232.93 + 1081.078 = CHF4,680 Mil.
Total Current Assets was CHF4,124 Mil.
Total Assets was CHF19,625 Mil.
Property, Plant and Equipment(Net PPE) was CHF1,744 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF881 Mil.
Selling, General, & Admin. Expense(SGA) was CHF2,625 Mil.
Total Current Liabilities was CHF2,197 Mil.
Long-Term Debt & Capital Lease Obligation was CHF4,960 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1247.388 / 6633.316) / (1287.005 / 6599.959)
=0.188049 / 0.195002
=0.9643

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4679.611 / 6599.959) / (4764.178 / 6633.316)
=0.709036 / 0.71822
=0.9872

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3986.296 + 1781.834) / 18590.519) / (1 - (4124.473 + 1744.421) / 19625.086)
=0.689727 / 0.700949
=0.984

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6633.316 / 6599.959
=1.0051

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(881.153 / (881.153 + 1744.421)) / (853.95 / (853.95 + 1781.834))
=0.335604 / 0.323983
=1.0359

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2547.86 / 6633.316) / (2625.437 / 6599.959)
=0.384101 / 0.397796
=0.9656

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4334.896 + 2471.08) / 18590.519) / ((4960.025 + 2196.899) / 19625.086)
=0.366099 / 0.364682
=1.0039

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(912.792 - -162.481 - 1410.578) / 18590.519
=-0.018036

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zimmer Biomet Holdings has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.


Zimmer Biomet Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (LTS:0QQD) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings (LTS:0QQD) Headlines

No Headlines